The Road to Toxin-Targeted Therapeutic Antibodies
ABSTRACT Once an infection by a toxin-producing bacterium is well established, therapies such as antibiotics that target bacterial growth may have little impact on the ultimate patient outcome. In such cases, toxin-neutralizing antibodies offer an opportunity to block key virulence factors. New work...
Guardado en:
Autor principal: | Thomas R. Kozel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3d1bddd1cbb24a0e9caa0a0bec42643f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antibody-Mediated Inhibition of Ricin Toxin Retrograde Transport
por: Anastasiya Yermakova, et al.
Publicado: (2014) -
Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious <named-content content-type="genus-species">Staphylococcus aureus</named-content> Disease
por: C. Tkaczyk, et al.
Publicado: (2016) -
Global Analysis of the Specificities and Targets of Endoribonucleases from Escherichia coli Toxin-Antitoxin Systems
por: Peter H. Culviner, et al.
Publicado: (2021) -
New Players in the Toxin Field: Polymorphic Toxin Systems in Bacteria
por: Anne Jamet, et al.
Publicado: (2015) -
Modular Lipoprotein Toxins Transferred by Outer Membrane Exchange Target Discrete Cell Entry Pathways
por: Christopher N. Vassallo, et al.
Publicado: (2021)